^99mTc Auger electrons for targeted tumour therapy: A review

References

• Adelstein S, Kassis A. 1996. Strand breaks in plasmid DNA following positional changes of auger-electron-emitting radionuclides. Acta Oncologica 35:797–801.
   PubMed Web of Science ®Google Scholar
• Behr T, Béheé M, Löhr M, Sgouros G, Angerstein C, Wehrmann E, Nebendahl K, Becker W. 2000. Therapeutic advantages of Auger electron-over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies. European Journal of Nuclear Medicine 27:753–765.
   PubMedGoogle Scholar
• Boswell C, Brechbiel M. 2005. Auger electrons: Lethal, low energy, and coming soon to a tumor cell nucleus near you. Journal of Nuclear Medicine 46:1946–1947.
   PubMed Web of Science ®Google Scholar
• Boyd M, Ross S, Dorrens J, Fullerton N, Tan K, Zalutsky M, Mairs R. 2006. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with α−, β−, and auger electron-emitting radionuclides. Journal of Nuclear Medicine 47:1007–1015.
   PubMed Web of Science ®Google Scholar
• Buchegger F, Perillo-Adamer F, Dupertuis Y, Delaloye A. 2006. Auger radiation targeted into DNA: A therapy perspective. European Journal of Nuclear Medicine and Molecular Imaging 33:1352–1363.
   PubMed Web of Science ®Google Scholar
• Britz-Cunningham S, Adelstein S. 2003. Molecular targeting with radionuclides: State of the science. Journal of Nuclear Medicine 44:1945–1961.
   PubMed Web of Science ®Google Scholar
• Chen P, Wang J, Hope K, Jin L, Dick J, Cameron R, Brandwein J, Minden M, Reilly R. 2006. Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells. Journal of Nuclear Medicine 47:827–836.
   PubMed Web of Science ®Google Scholar
• Faraggi M, Gardin I, Labriolle-Vaylet C, Moretti J, Bok B. 1994. The influence of tracer localization on the electron dose rate delivered to the cell nucleus. Journal of Nuclear Medicine 35:113–119.
   PubMed Web of Science ®Google Scholar
• Ftácniková S, Böhm R. 2000. Monte Carlo calculations of energy deposition in DNA for Auger emitters. Radiation Protection Dosimetry 92:269–278.
   Web of Science ®Google Scholar
• Ginj M, Hinni K, Tschumi S, Schulz S, Maecke H. 2005. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using Auger electron emitters. Journal of Nuclear Medicine 46:2097–2013.
   PubMed Web of Science ®Google Scholar
• Goddu S, Howell R, Rao D. 1994. Cellular dosimetry: Absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. Journal of Nuclear Medicine 35:303–316.
   PubMed Web of Science ®Google Scholar
• Griffiths G, Govindan S, Sgouros G, Ong G, Goldenberg D, Mattes M. 1999. Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies. International Journal of Cancer 81:985–992.
   PubMed Web of Science ®Google Scholar
• Guiraud-Vitaux F, Jacquet N, Petiet A, Roy L, Voisin P, Colas-Linhart N. 2005. Induction of unstable and stable chromosomal aberrations by 99mTc: In-vitro and in-vivo studies. Nuclear Medicine Communications 26(10):913–918.
   PubMed Web of Science ®Google Scholar
• Häefliger P, Agorastos N, Spingler B, Georgiev O, Viola G, Alberto R. 2005a. Induction of DNA-double-strand breaks by Auger electrons from 99mTc complexes with DNA-binding ligands. ChemBioChem 6:414–421.
   PubMed Web of Science ®Google Scholar
• Häefliger P, Agorastos N, Renard A, Giambonini-Brugnoli G, Marty C, Alberto R. 2005b. Cell uptake and radiotoxicity studies of na nuclear localization signal peptide-intercalator conjugate labeled with [99mTc(CO)3]+. Bioconjugate Chemistry 16:582–587.
   PubMed Web of Science ®Google Scholar
• Hofer K. 2000. Biophysical aspects of Auger process. Acta Oncologica 39:651–657.
   PubMed Web of Science ®Google Scholar
• Howell R. 1992. Radiation spectra for Auger-electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Medical Physics 19:1371–1383.
   PubMed Web of Science ®Google Scholar
• Humm J, Charlton D. 1989. A new calculational method to assess the therapeutic potential of Auger electron emission. International Journal of Radiation Oncology Biology Physics 17:351–360.
   PubMed Web of Science ®Google Scholar
• Humm J, Howell R, Rao D. 1994. Dosimetry of Auger-electron-emitting radionuclides. Medical Physics 21:1901–1915.
   PubMed Web of Science ®Google Scholar
• Ílknur A, Vardereli E, Durak B, Gülbas Z, Basaran N, Stokkel M, Pauwels E. 2002. Labelling of mixed leukocytes with 99mTc-HMPAO causes severe chromossomal aberrations in lymphocytes. Journal of Nuclear Medicine 43:203–206.
   PubMed Web of Science ®Google Scholar
• Jacquet N, Bourahla K, Guiraud-Vitaux F, Petiet A, Voisin P, Colas-Linhart N. 1999. Biological consequences of irradiation by low doses of technetium 99m: Ultrastructural studies, p53 protein expression and cytogenetic effects. Cellular and Molecular Biology 45(8):1139–1147.
   PubMed Web of Science ®Google Scholar
• Kassis A. 2003. Cancer therapy with Auger electrons: Are we almost there? Journal of Nuclear Medicine 44:1479–1481.
   PubMed Web of Science ®Google Scholar
• Kriehuber R, Kadenbach K, Schultz F, Weiss D. 2004. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the Auger electron emitter Tc-99m. International Journal of Radiation Biology 80:875–880.
   PubMed Web of Science ®Google Scholar
• Mairs R, Fullerton N, Zatalutsky M, Boyd M. 2007. Targeted radiotherapy: Microgray doses and the bystander effect. Dose-Response 5:204–213.
   PubMedGoogle Scholar
• Mariani G, Bodel L, Aldestein S, Kassis A. 2000. Emerging roles for radiometabolic therapy of tumors based on auger electron emission. Journal of Nuclear Medicine 41:1519–1521.
   PubMed Web of Science ®Google Scholar
• Marques F, Paulo A, Campello M, Lacerda S, Vitor R, Gano L, Delgado R, Santos I. 2005. Radiopharmaceuticials for targeted radiotherapy. Radiation Protection Dosimetry 116:601–604.
   PubMed Web of Science ®Google Scholar
• O'Donnell R. 2006. Nuclear localizing sequences: An innovative way to improve targeted radiotherapy. Journal of Nuclear Medicine 47:738–739.
   PubMed Web of Science ®Google Scholar
• O'Donoghue J, Wheldon T. 1996. Targeted radiotherapy using Auger electrons emitters. Physics in Medicine and Biology 41:1973–1992.
   PubMed Web of Science ®Google Scholar
• Pedraza-López M, Ferro-Flores G, Mendiola-Cruz M, Morales-Ramírez P. 2000. Assessment of radiation-induced DNA damage caused by the incorporation of Tc-99m-radiopharmaceuticals in murine lymphocytes using cell gel electrophoresis. Mutation Research 465:139–144.
   PubMed Web of Science ®Google Scholar
• Pomplun E, Terrissol M, Kümmerle E. 2006. Estimation of radiation weighting factor for 99mTc. Radiation Protection Dosimetry 122:80-81.
   PubMed Web of Science ®Google Scholar
• Sastry K. 1992. Biological effects of the Auger emitter Iodine-125: A review. Report No. 1 of AAPM Nuclear Medicine Task Group No. 6. Medical Physics 19:1361–1370.
   PubMed Web of Science ®Google Scholar
• Schipper M, Riese C, Seitz S, Weber A, Béhé M, Schurrat T, Scharamm N, Keil B, Alfke H, Behr T. 2007. Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo. European Journal of Nuclear Medicine and Molecular Imaging 34:638–650.
   PubMed Web of Science ®Google Scholar
• Sofou S. 2008. Radionuclide carriers for targeting of cancer. International Journal of Nanomedicine 3:181–199.
   PubMed Web of Science ®Google Scholar
• Stepanek J, Larsson B, Weinreich R. 1996. Auger-electron spectra of radionuclides for therapy and diagnosis. Acta Oncologica 35:863–868.
   PubMed Web of Science ®Google Scholar
• Unak P. 2002. Targeted tumor radiotherapy. Brazilian Archives of Biology and Technology 45:97–110.
   Web of Science ®Google Scholar
• Urashima T, Nagasawa H, Wang K, Adelstein S, Little J, Kassis A. 2006. Induction of apoptosis in human tumor cells after exposure to auger electrons: Comparation with gamma-ray exposure. Nuclear Medicine and Biology 33:1055–1063.
   PubMed Web of Science ®Google Scholar
• Watanabe N, Sawai H, Ogihara-Umeda I, Tanada S, Kim E, Yonekura Y, Sasaki Y. 2006. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-Labeled N-myc antisense oligonucleotides. Journal of Nuclear Medicine 47:1670–1677.
   PubMed Web of Science ®Google Scholar